The Seattle tech scene has pulled in a decent amount of venture capital over the summer, rounding out August with five substantial rounds totaling $212.6 million. From biotech and healthcare to eco-friendly solutions, learn how these companies are growing with their latest funding rounds.
Top Seattle Tech Funding Rounds, August 2023
- Viome Life Sciences
- INRIX
- Hyperproof
- Electric Era
- Membrion
#5. $5.5 million, August 8
Membrion provides businesses with ceramic desalination membranes that help manufacturers recycle wastewater. The company pulled in $5.5 million to put toward its Series B round, capping the raise at $12.5 million. Membrion’s investors include Samsung Venture Investment Corporation and Lam Capital.
#4. $11.5 million, August 23
Series A capital for EV charging company Electric Era will help the innovator expand its network of fast-charging stations across the country. The company plans to install 10,000 stations in locations like convenience stores and quick-service retail businesses by the end of the decade.
#3. $40 million, August 30
Hyperproof works to help compliance, risk and security teams gain complete visibility into their organizational risks, streamline the audit process and reduce their compliance workloads. The company announced a $40 million round of funding led by Riverwood Capital that’ll go toward expanding its enterprise offerings and developing new tech that uses advanced heuristics and AI.
#2. $70 million, August 8
Headquartered in Kirkland, INRIX equips cities and businesses with transportation analytics and connected car services. The company secured $70 million in financing from Morgan Stanley Investment Management to fuel its growth initiatives. The money will also help the company fuel innovation and expand its customer base.
#1. $85.6 million, August 18
With money from an oversubscribed seed round from investors like Khosla Ventures, Bold Capital and WRG Ventures, biotech platform Viome wants to develop and expand its suite of personalized health tests. The Bellevue-based company uses a science-based approach to compute outcomes for consumers based on their unique gene expressions.
